GeneEx is developing rapid, point-of-care diagnostic tests for infectious diseases capable of detecting virulence markers produced ONLY during active infections. Unlike current diagnostic assays, GeneEx's tests can detect pathogens in action as opposed to when they are just harmless colonizers. GeneEx will focus its initial commercialization effort on infectious diseases such as periodontitis, group A strep and systemic fungal infections. With a unique combination of patented technologies, an experienced management team, a gifted scientific and advisory team and products with shortened regulatory pathways, GeneEx is poised to make a substantial impact in the medical community.